Zhejiang Hisun Pharmaceutical Co., Ltd.

Zhejiang Hisun Pharmaceutical Co., Ltd. has seen a significant rise in stock performance, reaching an intraday high and reflecting positive market sentiment. Over the past year, the company has outperformed the broader market index, despite recent short-term challenges. It maintains a strong financial position within the pharmaceuticals sector.

Zhejiang Hisun Pharmaceutical Co., Ltd. saw a notable decline in its stock price, contrasting with the broader market's performance. Over the past week and month, the stock has decreased significantly, while year-to-date figures show a slight drop. The company maintains a market capitalization of CNY 11,262 million and a price-to-earnings ratio of 25.00.

Zhejiang Hisun Pharmaceutical Co., Ltd. has shown strong performance recently, with a year-to-date increase of 4.85% and a one-year return of 21.71%. The company, with a market capitalization of CNY 11,262 million, maintains a price-to-earnings ratio of 25.00 and a dividend yield of 2.25%.